 (J Clin Pathol: Mol Pathol 1999;52:37-41) 
Although Hodgkin's disease has been known for a long time, the lineage of its neoplastic elements-H/R-S cells and their variants-is still a matter of controversy. B cell, T cell, and monocyte markers have been detected by immunohistochemistry on H/R-S cells. 1 However, the detection of B and T cell associated antigens does not necessarily imply that these proteins, which might be absorbed from the microenvironment, are synthesised by the H/R-S cells. In situ hybridisation detected light chain mRNA in lymphocytic and/or histiocytic cells of lymphocyte predominant Hodgkin's disease [2] [3] [4] ; however, a similar positive signal has not been detected in H/R-S cells of classic Hodgkin's disease (R Von Wasielewski, et al. Presented at the third international symposium on Hodgkin's lymphoma, Cologne Germany, 1995). Southern blot hybridisation and routine polymerase chain reaction (PCR) for immunoglobulin or T cell receptor gene rearrangement does not allow an accurate explanation of the origin of clonal or polyclonal gene rearrangements, 1 and it is most likely that these gene rearrangements result from the large background population of cells in the tissue of Hodgkin's disease. Therefore, it is very diYcult to determine the cell lineage of H/R-S cells because Hodgkin's disease has special histological characteristics distinct from other tumours: a small number of H/R-S cells (usually less than 1%) among a large number of reactive background cells. A major obstacle in defining the nature of H/R-S cells has been obtaining a pure population for study. Molecular analysis of single H/R-S cells is the best way to confirm the nature of these cells.
In 1994, Küppers et al picked single H/R-S cells from histological sections of Hodgkin's disease tissue and found that these cells had immunoglobulin heavy chain (IgH) and light chain gene rearrangements. 5 In fact, the method (molecular histology) is an improved technique for the extraction of cell DNA, which excludes the DNA of background cells from the template DNA and allows one to determine unambiguously the origin of amplification products. In their report, the DNA from single H/R-S cells was amplified with IgH and light chain gene family specific primers, 6 but not with a light chain gene primer (the reason that light chain restriction almost always involves the light chain remains to be explained). No light chain gene rearrangements were found in the single H/R-S cells obtained from nodular sclerosis-type Hodgkin's disease tissue samples. However, the possibility that these H/R-S cells derived from another cell lineage (T cells) cannot be excluded entirely because T cell associated antigens are found on H/R-S cells in this subtype of Hodgkin's disease.
In our study, we micropicked single H/R-S cells from frozen tissue sections. PCR for Ig gene rearrangements was performed with an IgH chain gene common primer and and light chain gene family specific primers, with the aim of further investigating the nature of H/R-S cells.
Methods

TISSUES
Frozen lymph nodes aVected by Hodgkin's disease (one case of lymphocyte predominant Hodgkin's disease, two cases of nodular sclerosis-type Hodgkin's disease, and five cases of mixed cellularity-type Hodgkin's disease) came from the Department of Pathology, West China University of Medical Science.
IMMUNOHISTOCHEMISTRY
Frozen sections (10-15 µm thick) were cut and immunostained with BerH 2 , (Dakopatts, Glostrup, Denmark). The slides were counterstained with haematoxylin. In addition, the sections of paraYn wax embedded tissue were immunostained with anti-and anti-light chain monoclonal antibodies (Dackopatts).
ISOLATION OF SINGLE H/R-S CELLS
The stained, frozen sections were incubated with 5 mg/ml collagenase (Boehringer, Mannheimn, Germany) for three to four hours at 56°C. Under the microscope at a certain magnification, the single H/R-S cells with CD30 positive stained cytoplasm were carefully isolated using a micropipette (20-25 µm in diameter) attached to a hydraulic micromanipulator (WR-89; Nairishiger, Japan), and then transferred to Eppendorf tubes that contained 32 µl 1× PCR buVer and stored at −20°C (fig 1) .
PCR OF SINGLE H/R-S CELLS
The primers used for analysis of IgH chain gene rearrangement contained FRIIIa that was designed for the third framework region of the V H region, and LJH and VLJH that were designed for the J H region. The amplification of the V H D H J H fragment yields a product of ∼ 80-120 bp in length. [7] [8] [9] Family specific primers were used for detecting both light chain gene rearrangements. 10 11 It is possible to diVerentiate monoclonal from polyclonal B cell proliferation. In a clonal population, only one or two V genes are rearranged and give rise to a PCR product in the reaction with the V primer of the respective V gene family, whereas in a polyclonal population all, or at least most, of the V gene family rearrangements are present. Both the light chain gene family specific primers were designed for the framework region I. The amplified fragment is ∼ 350 bp in length. 10 11 A semi-nested PCR approach was chosen 6 and carried out using a PE480 DNA hot cycle appliance. Single cells in Eppendorf tubes were incubated with 0.25 mg/ml proteinase K for two hours at 56°C. The enzyme was inactivated bv heating to 95°C for 10 minutes. The first round of amplification was carried out in 50 µl volumes that contained 50 mM KCl, 10 mM Tris-HCl (pH 8.4), 0. 01% gelatin, 2.5 mM MgC1 2 , 800 µM dNTPs, 2.8 nM each of the FRIIIa and LJH primers, or a mixture of all V and J primers, or a mixture of all V and J primers, and 2 U Taq DNA polymerase, hot start. The cycle programme consisted of 40 cycles of 95°C for 90 seconds, 59°C for 30 seconds, and 72°C for 80 seconds. In the first round, we added 2.8 nM each of three -globin primers (PC40, GH2O, and PE) to determine whether it would be appropriate to perform the
Figure 1 Procedure for isolating a single H/R-S cell. (A) A typical H/R-S cell is shown in the middle of the picture, with a double nucleus and CD30 positive cytoplasm. Haematoxylin and eosin stained; magnification, ×200. (B) Picking the cell up with the micropipette. (C) The H/R-S cell in the micropipette. (D) After isolation of the cell, there is a hole where the cell was located, with a small rim of cytoplasm and nucleus.
second round of amplification. A specific product of 268 bp, detected by polyacrylamide gel electrophoresis, implied that the DNA from a single H/R-S cell was suitable for the second round of amplification.
The second round of amplification was carried out in separate reactions for VLJH and each of the V or V family specific primers, using 2 µl of the first round reaction mixture in a 50 µl volume that contained 50 mM KC1, 10 mM Tris-HC1 (pH 8.4), 0.01% gelatin, 2.5 mM MgCl 2 , 800 µM dNTPs, 0.2 µM of each FRIIIa and VLJH, or 0.25 µM of each V and J primer mixture, or each V and J primer mixture, and 2 U of Taq DNA polymerase, hot start. The cycle programme consisted of 40 cycles of 95°C for 90 seconds, 61°C, for 30 seconds, and 72°C for 80 seconds. A 10 µl aliquot of the reaction mixture was analysed on an 8% polyacrylamide gel. The amplified products were visualised under ultraviolet light after ethidium bromide staining.
CONTROL EXPERIMENTS
One case of a follicular centre cell lymphoma was used as a positive control for the detection of IgH chain gene rearrangement. One case of lymphadenopathy was used as a positive control for amplification with both light chain gene primers. In negative controls no DNA was added.
Results
CONTROL EXPERIMENTS
In the positive control, a specific 80 bp band was seen after electrophoresis. The amplification with DNA from the tissue sample of lymphadenopathy gave rise to a product of ∼ 350 bp in reactions with every and gene family specific primer, which indicated that a polyclonal population of B cells was present in the specimen. Therefore, we concluded that the PCR method and family specific primers that we were using were suitable for detecting Ig gene rearrangements in single H/R-S cells. No bands were seen in the negative control. 
PCR ANALYSIS OF SINGLE H/R-S CELLS
PCR specific products of the IgH, , and genes were not amplified from all single cells. There are several possible reasons for this (which might prove to be methological limitations) 5 6 12 13 : (1) part of the cell nucleus may have been missing: the larger the cell, the lower the likelihood of obtaining the entire cell nucleus; (2) certain unknown V gene rearrangements might not be detected with the primers used; (3) DNA might be destroyed in the histological tissue processing; (4) some genes might have the germline configuration; and (5) the chosen primers might not cover all regions of the V gene. For example, FRIIIa is designed for the third framework region of V H , it hybridises to the 3' end of most V H genes. However, with this primer, no information can be obtained about the particular V H genes rearranged, such as FRI/JH, FRII/JH rearrangements and even bcl-2/JH translation. The sensitivity in our study was ∼ 35.8%.
Unlike the method proposed by Küppers et al, in our method we added -globin gene primers to the first round of amplification to determine the usefulness of performing the next round of amplification. We showed that it was not necessary to carry out the next round of amplification if the -globin gene specific product was not detected in the first round (its presence indicates that DNA is available from the single cell), thereby reducing the number of PCR reactions that were carried out, and economising on reagents and time.
Fifty two of 135 single H/R-S cells isolated showed specific products in PCR reactions (36%). In the IgH gene, all the amplification products of single cells from a given biospy specimen were the same length (80 bp). In the Ig and light chain genes, the lengths of the products were also the same (350 bp).
In our study, many individual H/R-S cells were isolated from frozen sections. In most cases, many H/R-S cells from the same specimen produced a PCR product of the same size (80 bp for IgH, 350 bp for the light chain gene family). Therefore, there is a strong likelihood that these H/R-S cells are a clonal expansion or a monoclonal B cell population.
In addition, IgH and V 4 family products were found repeatedly in many H/R-S cells from one case of lymphocyte predominant Hodgkin's disease. In two cases of nodular sclerosis-type Hodgkin's disease, repeated V 4 and individual IgH/V 2,4 , and individual IgH and V 3 /V 4 products were seen (fig 3) . In five cases of mixed cellularity-type Hodgkin's disease, repeated IgH/V 3 and individual V 2,4 , repeated V 4 and individual IgH/V 3 , and repeated IgH and individual V 3 /V 4 family products were detected, respectively (fig 4) .
In patient 3 (nodular sclerosis-type Hodgkin's disease) and patient 7 (mixed cellularitytype Hodgkin's disease), one H/R-S cell had two light chain gene family rearrangements (V 2 and V 4 family in patient 3, V 2 and V 4 
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family in patients 7). This rearrangement might be just on two chromosomes (bi-allelic) and presumably on more than two chromosomes in a hyperploid H/R-S cell. Table 1 summarises the results of immunoglobulin gene rearrangements in single H/R-S cells of eight patients with Hodgkin's disease.
Discussion
The neoplastic elements of Hodgkin's disease-H/R-S cells and their variants-have been identified variously as B or T lymphocytes, monocytes, and even as dendritic cells. The major diYculty in determining the origin of these malignant cells lies in the disturbance caused by background cells. However, the "molecular histology" technique proposed by Küppers et al enables one to pick out individual H/R-S cells with typical morphology and surface markers in a histological section of tissue aVected by Hodgkin's disease and determine whether the monoclonal or polyclonal rearrangements are derived from H/R-S cells or from other background cells in the specimen. Using this approach, ourselves and other workers have shown that Ig gene rearrangements occur in single H/R-S cells, so that it has gradually become clear that B cell malignant transformation occurs in these cells. 5 14 Lymphocyte predominant Hodgkin's disease is a distinctive and rare form of the disease that is clinically indolent and has an excellent prognosis. The presence of H/R-S cells among a background of small lymphocytes and histiocytes has recently been classified as a special entity, distinct from classic Hodgkin's disease. 15 H/R-S cells of lymphocyte predominant Hodgkin's disease have special immunophenotypic and genotypic characteristics, diVerent from those of other subtypes of Hodgkin's disease. Expression of CD19, CD20, and CD45RB, but not of CD15 and CD30 is common. 1 The detection of restricted Ig light chain mRNA supports the theory that lymphocyte predominant Hodgkin's disease is a monoclonal proliferation of B cells. [7] [8] [9] In many cases of lymphocyte predominant Hodgkin's disease, H/R-S cells with the molecular features of a monoclonal population of B cells were found, which were negative for Epstein-Barr virus (EBV), except in a few cases. 16 17 However, some investigators have reported evidence of the B cell origin of H/R-S cells and the polyclonal nature of the disease. 18 Our experiments corroborate the view that H/R-S cells of lymphocyte predominant Hodgkin's disease originate from B lymphocytes because of the IgH and light chain gene rearrangements revealed in individual H/R-S cells of this type of Hodgkin's disease. These cells might represent a separate B cell clone, indicating a polyclonal population.
During B cell development, an IgH gene undergoes recombination through a rejoining of the V, D, and J regions, giving rise to a three part V H D H J H unit, which is called the complementary determining region III, and is a clonal signature of an individual B cell. If PCR is applied across this region, the lengths of the reaction products of diVerent clonal B cells tend to diVer. If single H/R-S cells from diVerent areas of a specimen from a patient with Hodgkin's disease have the same size PCR products, we can assume that these H/R-S cells are derived from the same B cell clone.
With this method, the origin of H/R-S cells in mixed cellularity and nodular sclerosis types of Hodgkin's disease have been determined convincingly by ourselves and other workers. 5 14 However, the clonality of H/R-S cells is discordant. Hansmann's group studied 14 cases of Hodgkin's disease, mainly of the two subtypes in 19 20 In our series, patients 1, 4, 6, and 7 had many cells expressing the same size of IgH rearrangement (80 bp). In addition to IgH, and light chain gene rearrangements were detected in all patients except patient 8. The same light chain gene rearrangements were present simultaneously in two individual H/R-S cells from the same specimen (V 4 in patients 3 and 5; V 3 in patient 7). This result was confirmed by identifying identical rearrangements in cells from different sections. However, the family of diVerent light chain gene rearrangements was also detected in cells from the same specimen (patients 2, 4, 5, and 7). Thus, it is likely that these cells in our series represented a diVerent clonal B cell population at various stages of development. These H/R-S cells in a given biopsy specimen might be descendants of a single B cell and therefore constitute a monoclonal population, or each H/R-S cell might be from a separate B cell clone.
Why does light chain restriction almost always involves the but not the light chain? During B cell development, functional heavy chain gene rearrangement is followed by gene rearrangement. If gene rearrangement on both chromosomes fails, the cell may proceed with gene rearrangement to yield a functional light chain gene. 21 In humans, ∼ 40% of B cells express the light chain. For this reason, at least some H/R-S cells should have rearranged light chain genes. Our study showed this to be true: in addition to V 3 (patients 2 and 5 ) and V 4 family rearrangement, V 2,4 , two diVerent family rearrangements, which might be on just two chromosomes or on more than two chromosomes in hyperploid H/R-S cells, were detected.
There are still many questions to be answered about Hodgkin's disease, including: why H/R-S cells do not behave like EBV transformed B cells or the cells in any common B cell non-Hodgkin's lymphoma; how H/R-S cells stay alive; and the clonality of H/R-S cells. It is hoped that more carefully planned studies in the future will provide new insights that will clarify this enigmatic disease.
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